Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Statins and diabetic hyperlipidemia].

B Vergès1

  • 1Service Endocrinologie, Diabétologie et Maladies métaboliques CHU de Dijon, Hôpital du Bocage, F-21000 Dijon. bruno.verges@chu-dijon.fr

Annales D'Endocrinologie
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Orphanet journal of rare diseases·2022
Same author

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism·2021
Same author

Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene.

Diabetes & metabolism·2020
Same author

[Thyroiditis: What's new in 2019?]

La Revue de medecine interne·2020
Same author

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).

Diabetes & metabolism·2019
Same author

A low-carbohydrate high-fat diet initiated promptly after diagnosis provides clinical remission in three patients with type 1 diabetes.

Diabetes & metabolism·2019

Type 2 diabetes often causes lipid abnormalities, including high triglycerides and low HDL cholesterol. While statins are recommended for diabetic hypercholesterolemia, their effectiveness for typical diabetic lipid profiles requires further investigation.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Pharmacology

Context:

  • Type 2 diabetes is frequently associated with dyslipidemia, including elevated triglycerides and reduced HDL cholesterol.
  • Diabetic dyslipidemia significantly increases the risk of cardiovascular events.
  • Current guidelines recommend statin therapy for hypercholesterolemia in diabetic patients.

Purpose:

  • To evaluate the efficacy of statins in managing typical diabetic hyperlipidemia (hypertriglyceridemia and low HDL cholesterol).
  • To assess the potential role of newer, more potent statins in treating diabetic dyslipidemia.

Summary:

  • Diabetic patients exhibit complex lipoprotein abnormalities beyond LDL cholesterol.
  • Statins have a moderate effect on triglycerides and HDL cholesterol in this population.

Related Experiment Videos

  • Newer statins like cerivastatin and atorvastatin may offer improved triglyceride-lowering effects.

    • Impact:

    • Further clinical trials are needed to confirm the cardiovascular benefits of statins in type 2 diabetes patients with specific lipid profiles.
    • Understanding statin efficacy in diabetic dyslipidemia can optimize cardiovascular risk reduction strategies.
    • This research highlights the need for tailored lipid management in type 2 diabetes.